|
Post by rossomalley on Sept 25, 2017 8:32:56 GMT -5
Most interesting so far is (finally!) another mention of RLS and confirmation that it's working on cannabinoids
|
|
|
Post by therealisaching on Sept 25, 2017 8:44:28 GMT -5
Mike C:
"Recapitalization process is underway and we should be able to share information shortly"
Replay is up & available for anyone who missed the presentation.
|
|
|
Post by kc on Sept 25, 2017 8:45:02 GMT -5
Why is urbanski still in the slide deck and he mentioned him.
|
|
|
Post by boca1girl on Sept 25, 2017 8:48:23 GMT -5
Why is urbanski still in the slide deck and he mentioned him. Ray is there to the end of the month and they haven't named a successor. Would have been nice if they could have named a replacement today.
|
|
|
Post by slugworth008 on Sept 25, 2017 10:51:55 GMT -5
Mike C:
"Recapitalization process is underway and we should be able to share information shortly"
Replay is up & available for anyone who missed the presentation. It's my hope that recapitalization doesn't mean dilution. Fingers crossed.
|
|
|
Post by celo on Sept 25, 2017 11:00:44 GMT -5
What do you think it means?
|
|
|
Post by lakers on Sept 25, 2017 11:02:29 GMT -5
|
|
|
Post by lakers on Sept 25, 2017 11:34:39 GMT -5
Targeted countries: Canada, Mexico, B, I, C (BRIC w/o R), Australia, Japan (new), Saudi Arabia (new), UAE, Oman (new), S Africa (new). That's > 50% of the World’s Population.
|
|
|
Post by peppy on Sept 25, 2017 12:39:16 GMT -5
Per Mike C
PDUFA date is this Friday. Nothing they are aware of would change this
*he mentioned again toward the end of the presentation. By Friday or possibly over the weekend. in this order.
|
|
|
Post by saxcmann on Sept 25, 2017 12:49:32 GMT -5
Per Mike C
PDUFA date is this Friday. Nothing they are aware of would change this
*he mentioned again toward the end of the presentation. By Friday or possibly over the weekend. in this order.
Big question is how much time between label and recapitalization? could be quick like a day or two?
|
|
|
Post by victoria on Sept 25, 2017 13:31:22 GMT -5
I'm interested in this list of 'targets'. Whats not mentioned? The whole of the EU, ie one fifth of the global economy, and the third largest GDP block in the world, with advanced (and enormous) healthcare provision and all the ailments of prosperous overfed populations.
I don't think that's necessarily an oversight. I wonder if that may imply that Mannkind is not targeting the EU (or literally any EU states individually either), because they might licence the EU market to another player with specific expertise in that market and its approval mechanisms.
Source:https://www.weforum.org/agenda/2017/03/worlds-biggest-economies-in-2017/
|
|
|
Post by mnkdfann on Sept 25, 2017 14:26:24 GMT -5
Did they offer to take questions from analysts at the end?
Were there any questions asked?
If so, by whom and what was asked / answered?
|
|
|
Post by op2778 on Sept 25, 2017 14:51:39 GMT -5
|
|
|
Post by lakers on Sept 25, 2017 14:58:10 GMT -5
International expansion announcement is something we saw where we’re focused on.
Receptor Life Sciences, we’re looking to bring more clarity to that collaboration for our shareholders.
Going forward, we expect to be able to remove prior authorizations and continue to gain more coverage with additional plan. Our STAT trial, which is really looking at Afrezza plus Dexcom will be – we’ll get those results in late fall and they’ll be presented next year, and we’re on track for an IND filing for Treprostinil.
|
|
|
Post by peppy on Sept 25, 2017 14:58:27 GMT -5
Per Mike C
PDUFA date is this Friday. Nothing they are aware of would change this
*he mentioned again toward the end of the presentation. By Friday or possibly over the weekend. in this order.
The weekly chart. Price out of the downtrend and off the bottom. Sideways work being done by price. I hope this is some sort of strange inverted head and shoulders. figuring 2.25 high and .67 low, 1.58 the difference. so just looking $2.25 plus $1.58 = $3.83. which is the reverse split adjusted sanofi low.
|
|